Capricor, Inc.

Capricor Therapeutics is a biotechnology company developing cell and exosome-based therapeutic candidates to treat diseases including Duchenne muscular dystrophy. The company's pipeline focuses on allogeneic cardiosphere-derived cells (CDCs) and exosome science as potential therapeutic approaches.